By Counterforce Health Team in Brensocatib (BRINSUPRI) —

If Brensocatib (BRINSUPRI) Isn't Approved by Humana in Ohio: Formulary Alternatives & Exception Paths

Answer Box: When Humana Denies Brensocatib (BRINSUPRI) in Ohio

If Humana denies coverage for Brensocatib (BRINSUPRI) in Ohio, you have three main options: try formulary alternatives like macrolide antibiotics first (often required by step therapy), request a formulary exception with clinical documentation, or pursue an internal appeal followed by Ohio's external review process. First step today: Contact your prescriber to document your bronchiectasis exacerbation history and any failed treatments, then call Humana at 1-800-457-4708 to confirm formulary status and prior authorization requirements.

Table of Contents

When Alternatives Make Sense

Before pursuing a lengthy appeals process, it's worth understanding when formulary alternatives might be appropriate for your situation. Humana typically requires step therapy for Brensocatib (BRINSUPRI), meaning you'll need to try preferred alternatives first unless you meet specific exception criteria.

Clinical situations where alternatives may work:

  • Mild to moderate bronchiectasis symptoms
  • Fewer than 3-4 exacerbations per year
  • No previous intolerance to macrolide antibiotics
  • Willingness to combine multiple therapies (antibiotics + airway clearance)

When to skip alternatives and go straight to exception requests:

  • History of macrolide intolerance or contraindications
  • Severe, frequent exacerbations (4+ per year) despite standard care
  • Failed multiple previous antibiotic regimens
  • Documented QT prolongation or cardiac rhythm concerns with macrolides
Note: Even if you plan to try alternatives, document your current symptoms and exacerbation frequency now. This baseline will be crucial if alternatives fail and you need to appeal later.

Typical Formulary Alternatives

Macrolide Antibiotics (First-Line Step Therapy)

Azithromycin (Z-Pak)

  • Typical regimen: 500mg three times weekly for bronchiectasis maintenance
  • Formulary status: Usually Tier 1-2 (generic available)
  • Coverage requirements: Prior authorization often not required for standard dosing

Clarithromycin (Biaxin)

  • Typical regimen: 500mg twice daily, may be reduced for maintenance
  • Formulary status: Tier 2-3 (brand and generic options)
  • Coverage requirements: May require prior authorization for extended use

Airway Clearance Therapies

High-Frequency Chest Wall Oscillation (HFCWO) Devices

Positive Expiratory Pressure (PEP) Devices

  • Examples: Acapella, Flutter valve, TheraPEP
  • Coverage: Usually covered with bronchiectasis diagnosis
  • Cost: Lower than HFCWO devices ($50-200 vs. $15,000+)

Inhaled Medications

Hypertonic Saline

  • Typical regimen: 3-7% solution twice daily via nebulizer
  • Coverage: Usually covered for bronchiectasis
  • Requirements: May need pulmonary function test documentation

Inhaled Antibiotics (Off-Label)

  • Examples: Tobramycin (TOBI), colistin
  • Coverage: Often requires prior authorization for bronchiectasis
  • Documentation needed: Culture results showing specific organisms

Pros and Cons Overview

Macrolide Antibiotics

Pros:

  • Lower cost and easier access
  • Established safety profile
  • Anti-inflammatory effects beyond antibiotic action
  • Can be combined with other therapies

Cons:

  • Potential for bacterial resistance with long-term use
  • QT prolongation risk (requires EKG monitoring)
  • Drug interactions (especially with warfarin, statins)
  • May not be as effective as Brensocatib for severe cases

Airway Clearance Devices

Pros:

  • Non-pharmacologic approach
  • No drug interactions or systemic side effects
  • Can be used indefinitely
  • May improve quality of life significantly

Cons:

  • Requires daily commitment (30+ minutes)
  • High upfront cost for HFCWO devices
  • May not address underlying inflammation
  • Effectiveness varies by patient compliance
From our advocates: We've seen patients successfully manage bronchiectasis symptoms for years using combination therapy with azithromycin plus daily airway clearance, particularly when they maintain consistent routines and work closely with pulmonary specialists for monitoring.

Exception Strategy

When formulary alternatives aren't appropriate, a well-documented exception request is your best path to Brensocatib coverage.

Medical Necessity Documentation Checklist

Essential elements for your prescriber's letter:

✓ Confirmed diagnosis: High-resolution CT showing bronchiectasis ✓ Symptom severity: Document exacerbation frequency (aim for 2+ per year) ✓ Failed alternatives: Specific drugs tried, doses, duration, and outcomes ✓ Contraindications: Any medical reasons alternatives can't be used ✓ Clinical rationale: Why Brensocatib is uniquely necessary ✓ Monitoring plan: Dermatologic and dental evaluation schedule

Supporting Evidence to Include

  • Recent CT scan results showing bronchiectasis pattern
  • Exacerbation history from the past 12-24 months
  • Antibiotic trial documentation with specific outcomes
  • Pulmonary function tests if available
  • Culture results showing resistant organisms (if applicable)

Timeline for Exception Requests

  • Standard review: 72 hours for Humana Medicare Advantage
  • Expedited review: 24 hours if delay would jeopardize health
  • Documentation: Submit via Humana provider portal or fax to 1-877-486-2621

Switching Logistics

Coordinating with Your Provider

Before starting alternatives:

  1. Schedule baseline assessments (EKG for macrolides, pulmonary function)
  2. Establish monitoring schedule (typically every 3-6 months)
  3. Set clear trial duration (usually 3-6 months for adequate assessment)
  4. Plan documentation strategy for potential future Brensocatib appeal

Pharmacy Coordination

For macrolides:

  • Usually available at retail pharmacies
  • Confirm 90-day supplies are covered for maintenance therapy
  • Check for drug interaction screening

For airway clearance devices:

  • Must use Humana-approved durable medical equipment (DME) suppliers
  • Requires separate prior authorization process
  • Delivery and setup typically included in coverage

Monitoring Requirements

Therapy Baseline Tests Follow-up Schedule Key Monitoring
Azithromycin EKG, hearing test Every 6 months QT interval, hearing
Clarithromycin EKG, liver function Every 3-6 months QT interval, drug levels
HFCWO devices None required As needed Compliance, skin integrity
Hypertonic saline Pulmonary function Every 6-12 months Bronchospasm, tolerance

Re-trying for Brensocatib Later

Documentation During Alternative Trials

Keep detailed records of:

  • Exacerbation dates and severity
  • Antibiotic courses required
  • Hospitalizations or ER visits
  • Quality of life impacts
  • Side effects or intolerances
  • Objective measures (sputum volume, exercise tolerance)

Criteria for "Failed" Alternative Therapy

For macrolides, document:

  • Continued exacerbations (2+ per year) despite 3-6 months of therapy
  • Intolerable side effects (GI upset, hearing changes, cardiac issues)
  • Drug interactions requiring discontinuation
  • Bacterial resistance development

For airway clearance:

  • Poor compliance due to time constraints or physical limitations
  • Inadequate symptom improvement after 6 months
  • Device-related complications or skin breakdown

Strengthening Your Future Appeal

When you've given alternatives a fair trial, your Brensocatib appeal becomes much stronger. Counterforce Health specializes in turning these documented treatment failures into compelling, evidence-backed appeals that address payers' specific denial reasons and formulary requirements.

Key appeal elements after failed alternatives:

  • Chronological treatment timeline showing progression
  • Comparative outcomes (exacerbations before/during alternatives)
  • Clinical deterioration despite standard care
  • Economic argument (hospitalization costs vs. drug costs)

Appeals Playbook for Humana in Ohio

Internal Appeals Process

Level 1: Standard Reconsideration

  • Timeline: 65 days from denial notice
  • Response time: 30 days (Part C), 7 days (Part D)
  • How to file: Call 1-800-457-4708 or submit via Humana member portal

Level 2: Independent Review Entity

  • Timeline: 60 days from Level 1 denial
  • Response time: 30 days
  • Automatic: Triggered if you don't request otherwise

Ohio External Review

If Humana's internal appeals are unsuccessful, Ohio residents have additional protection through the state's external review process.

Eligibility: Available for medical necessity denials after exhausting internal appeals Timeline: 180 days from final internal denial to request external review Process: File with Humana, who notifies Ohio Department of Insurance Response time: 30 days standard, 72 hours expedited Contact: Ohio Department of Insurance at 1-800-686-1526

Tip: Even if Humana claims your case isn't eligible for external review, the Ohio Department of Insurance can independently determine eligibility and order a review.

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documentation
"Not medically necessary" Demonstrate exacerbation frequency and severity CT scan, hospitalization records, antibiotic courses
"Formulary alternatives available" Document failed trials or contraindications Treatment timeline, side effect records, drug interaction list
"Experimental/investigational" Cite FDA approval and clinical guidelines FDA label, peer-reviewed studies
"Quantity limit exceeded" Justify dosing based on weight/severity Clinical notes supporting dosing rationale
"Non-network pharmacy" Switch to specialty pharmacy or request exception List of approved Humana specialty pharmacies

FAQ

How long does Humana prior authorization take in Ohio? Standard requests take up to 72 hours for Medicare Advantage plans. Expedited requests (when delay would jeopardize health) must be processed within 24 hours.

What if Brensocatib is completely non-formulary on my Humana plan? You can request a formulary exception by having your prescriber submit a medical necessity statement. The process is the same as prior authorization but requires stronger clinical justification.

Can I request an expedited appeal if I'm having frequent exacerbations? Yes, if delaying treatment would seriously jeopardize your health or functional capacity. Your prescriber must document the urgency in their supporting letter.

Does step therapy apply if I failed macrolides outside of Ohio or before joining Humana? Previous treatment failures should count toward step therapy requirements, but you'll need documentation from your prior providers. Humana may request medical records to verify the trials.

What counts as "failed" macrolide therapy for step therapy purposes? Typically, continued exacerbations despite 3-6 months of appropriate dosing, intolerable side effects requiring discontinuation, or medical contraindications to macrolide use.

How much does Brensocatib cost if my appeal is denied? The list price is approximately $88,000 per year. However, manufacturer patient assistance programs may be available through Insmed. Check their website for current eligibility criteria.

Can I use GoodRx or other discount programs for Brensocatib? Traditional discount programs typically don't cover specialty medications like Brensocatib. Focus on manufacturer assistance programs and foundation grants for rare diseases.

What happens if I move from Ohio to another state during my appeal? Your Humana coverage terms should remain the same, but external review rights will transfer to your new state's process. Contact the new state's insurance department for specific procedures.

Understanding your options when Brensocatib is initially denied helps you make informed decisions about your bronchiectasis care. Whether pursuing alternatives or exception requests, thorough documentation and persistence are key to eventual success.

Counterforce Health helps patients, clinicians, and specialty pharmacies navigate these complex approval processes by turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to identify the specific criteria needed for approval, then drafts point-by-point rebuttals using the right clinical evidence and procedural requirements.

Sources & Further Reading

This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider before making treatment decisions. Coverage policies and requirements may change; verify current information directly with Humana and consult the Ohio Department of Insurance for the most up-to-date appeals procedures.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.